![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Cole L A, Sutton J M. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer. Journal of Reproductive Medicine 2004; 49: 545–553
- Er T K, Jong Y J, Tsai E M, et al. False-negative pregnancy test in hydatidiform mole. Clinical Chemistry 2006; 52: 1616–1618
- Kohorn E I, Cole L. Nicked human chorionic gonadotrophin in trophoblastic disease. International Journal of Gynecological Cancer 2000; 10: 330–335
- Johns J, Greenwold N, Buckley S, et al. A prospective study of ultrasound screening for molar pregnancies in missed miscarriages. Ultrasound in Obstetrics and Gynecology 2005; 25: 493–497
- RCOG. The management of gestational trophoblastic neoplasia. Guideline no. 38. Royal College of Obstetricians and Gynaecologists, London 2004
- Sebire N J, Rees H, Paradinas F, et al. The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancies. Ultrasound in Obstetrics and Gynecology 2001; 18: 662–665